Lunit Future Growth
Future criteria checks 5/6
Lunit is forecast to grow earnings and revenue by 78.2% and 49.9% per annum respectively. EPS is expected to grow by 36.2% per annum. Return on equity is forecast to be 2% in 3 years.
Key information
78.2%
Earnings growth rate
36.2%
EPS growth rate
| Healthcare Services earnings growth | 31.2% |
| Revenue growth rate | 49.9% |
| Future return on equity | 2.0% |
| Analyst coverage | Low |
| Last updated | 19 Nov 2024 |
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 128,743 | 13,964 | 24,600 | 42,800 | 2 |
| 12/31/2025 | 87,495 | -19,839 | -27,000 | -12,000 | 3 |
| 12/31/2024 | 55,500 | -27,684 | -30,900 | 10,900 | 1 |
| 9/30/2024 | 39,537 | -21,974 | -70,504 | -63,342 | N/A |
| 6/30/2024 | 26,034 | -22,057 | -56,292 | -51,402 | N/A |
| 3/31/2024 | 19,249 | -46,024 | -47,737 | -46,036 | N/A |
| 12/31/2023 | 25,080 | -36,798 | -38,065 | -36,473 | N/A |
| 9/30/2023 | 23,626 | -39,226 | -40,038 | -39,145 | N/A |
| 6/30/2023 | 24,805 | -44,762 | -44,178 | -41,119 | N/A |
| 3/31/2023 | 21,861 | -19,443 | -47,155 | -43,678 | N/A |
| 12/31/2022 | 13,866 | -39,118 | -56,982 | -53,019 | N/A |
| 9/30/2022 | 14,017 | -42,801 | -52,629 | -48,482 | N/A |
| 6/30/2022 | 10,715 | -52,413 | -44,755 | -43,201 | N/A |
| 3/31/2022 | 9,076 | -85,907 | -43,396 | -42,233 | N/A |
| 12/31/2021 | 6,639 | -73,676 | -33,478 | -32,725 | N/A |
| 12/31/2020 | 1,430 | -83,739 | -17,600 | -16,754 | N/A |
| 12/31/2019 | 198 | -46,972 | -10,416 | -10,000 | N/A |
| 12/31/2018 | 20 | -8,210 | -6,763 | -5,861 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A328130 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.7%).
Earnings vs Market: A328130 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: A328130 is expected to become profitable in the next 3 years.
Revenue vs Market: A328130's revenue (49.9% per year) is forecast to grow faster than the KR market (9.3% per year).
High Growth Revenue: A328130's revenue (49.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A328130's Return on Equity is forecast to be low in 3 years time (2%).